|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Outcomes after arthroscopic repair of rotator cuff tears in the setting of mild to moderate glenohumeral osteoarthritis显示文摘BACKGROUND Rotator cuff pathology is a very common source of shoulder pain.Similarly,osteoarthritis of the glenohumeral joint can cause shoulder pain and produce similar symptoms.Surgical management can be indicated for both pathologies,however,outcomes data is limited when examining rotator cuff repair(RCR) in the setting of glenohumeral arthritis(GHOA).Thus,this study sought to determine outcomes for patients who undergo RCR in the setting of GHOA.AIM To evaluate if a relationship exists between outcomes of RCR in the setting of GHOA.METHODS This was a retrospective analysis of patients who underwent arthroscopic rotator cuff repair with concurrent glenohumeral osteoarthritis between 2010-2017.Patients were stratified based on rotator cuff tear size and glenohumeral osteoarthritis severity.Cohorts were paired 1:1 with patients without glenohumeral osteoarthritis.Patients included had a minimum two year follow-up.Rate of conversion to total shoulder arthroplasty,complication rates following initial surgery,and patient-reported outcome measures were collected.RESULTS A total of 142 patients were included.The number of patients that required total shoulder arthroplasty within two years after index surgery was low.2/71(2.8%) patients with GHOA,and 1/71(1.4%) without GHOA.Following rotator cuff repair,both groups showed favorable patientreported outcomes.CONCLUSION Patients with glenohumeral osteoarthritis who underwent arthroscopic rotator cuff repair showed comparable outcomes to patients without glenohumeral osteoarthritis. | Ian S Hong Allison J Rao Tyler L CarlLee Joshua D Meade Daniel J Hurwit Gregory Scarola David P Trofa Shadley C Schiffern Nady Hamid Patrick M Connor James E Fleischli Bryan Michael Saltzman | 2022 | World Journal of Orthopedics2022，13，7： | 2 |
| 2 | The vascu-lar system as a target of metal toxicity显示文摘 | Walter C P Joshua R E Daniel W N | 2008 | ToxicolSci2008，102，： | 1 |
| 3 | Protein identification using sequential ion/ion reactions and tandem mass spectrometry显示文摘 | JOSHUA J C BEATRIX U JOHN E P S | 2005 | Proc Natl cad Sci USA72005，102，27： | 1 |
| 4 | Ustekinumab: targeting the IL-17 path- way to improve outcomes in psoriatic arthritis显示文摘 | Joshua E Weitz C | 2014 | Expert Opin Biological Ther2014，14，4： | 1 |
| 5 | A Quantitative risk-benefit analysis of changes in population fish consumption显示文摘 | Joshua T Cohen D C Bellinger W E Conor | 2005 | Am J Prey Med2005，29，4： | 1 |
| 6 | Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial 显示文摘 | Carly E Renee C Joshua Lockwood | 2013 | Therapeutic advances in gastroenterology2013，6，4： | 1 |
| 7 | Cadmium, diabetes and chronic kidney disease 显示文摘 | JOSHUA R E WALTER C P | 2009 | Toxicology and Applied Pharmacology2009，238，： | 1 |
| 8 | Reaction of 1-aryl-,1,3-diaryl-and 1-alkyl-3-aryl-S-alkylisothiou-Reas with 4-alkyl/aryl thiosemicarbazides:formation of 4-alkyl/aryl-3-arylamino-5-mercapto-1,2,4-triazo-les and 2,5-diarylamino-1,3,4-thiadiazoles显示文摘 | Joshua C P Annie V A Rgh S E | 1990 | Journal of the Indian Chemical Society1990，67，9： | 1 |
| 9 | Review of health risks of low testosterone and testosterone administration显示文摘Hypogonadism is prevalent in older men and testosteronereplacement therapy(TRT) for older hypogonadal men is a promising therapy. However, a number of important clinical concerns over TRT safety remain unsolved due to a lack of large-scale randomized clinical trials directly comparing the health risks of untreated hypogonadism vs long-term use of TRT. Meta-analyses of clinical trials of TRT as of 2010 have identified three major adverse events resulting from TRT: polycythemia, an increase in prostate-related events, and a slight reduction in serum high-density lipoprotein cholesterol. There are other purported health risks but their incidence can be neither confirmed nor denied based on the small number of subjects that have been studied to date. Furthermore, subsequent literature is equivocal with regard to the safety and utility of TRT and this topic has been subject to contentious debate. Since January 2014, the United States Food and Drug Administration has released two official announcements regarding the safety of TRT and clinical monitoring the risks in TRT users. Additionally, the health risks related to the clinical presentation of low or declining testosterone levels not been resolved in the current literature. Because TRT is prescribed in the context of putative risks resulting from reduced testosterone levels, we reviewed the epidemiology and reported risks of low testosterone levels. We also highlight the current information about TRT utilization, the risks most often claimed to be associated with TRT, and current or emerging alternatives to TRT. | Huanguang Jia Charles T Sullivan Sean C McCoy Joshua F Yarrow Matthew Morrow Stephen E Borst | 2015 | World Journal of Clinical Cases2015，3，4： | 1 |
| 10 | Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms显示文摘 | THOMAS C C THOMAS E S JOSHUA J G | 2003 | J Neurosci2003，，10： | 1 |
| 11 | Dust transport in photoelectron layers and the formation of dust ponds on EROS显示文摘 | Joshua E C Amanda A G Scott R | 2005 | Icarus2005，175，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员